GlassScriptPhysician profile
Reed L Bartz
NPI 1881643971
$1,230,878.14
in general payments reported to CMS, 2019-2025
21 companies · $3,097 in 2025
The $3,097 reported for 2025 was more than what 75% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,302 · 2020: $469 · 2021: $1.2M · 2022: $384 · 2023: $485 · 2024: $2,354 · 2025: $3,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,120 · Travel and Lodging: $2,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,119.60 |
| Travel and Lodging | $2,816.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $1,222,748.64 | 2021 | |
| Stryker Corporation | $3,473.80 | 2019-2025 | Mako, Gamma, Hydroset |
| Arthrex, INC. | $1,069.90 | 2025 | |
| Pylant Medical | $789.14 | 2019-2025 | |
| Bone Support INC. | $623.51 | 2019-2025 | Cerament G, Ceramentbone Void Filler |
| Integra Lifesciences Corporation | $519.57 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Innovasis INC | $408.98 | 2023-2024 | |
| Depuy Synthes Sales INC. | $334.72 | 2022-2024 | Na, Tfn-Advance, Monovisc |
| Smith+Nephew, INC. | $286.58 | 2019 | |
| Medacta USA, INC. | $146.55 | 2020 | |
| Innovation Technologies INC | $102.29 | 2022-2025 | Irrisept |
| Conformis, INC. | $91.75 | 2020 | |
| Orthofix Medical, INC. | $57.16 | 2022-2025 | Physio-Stim |
| Siemens Medical Solutions USA, INC. | $37.63 | 2024 | Magnetom Free.Max |
| Moximed, INC | $34.74 | 2024 | Misha Knee System, Small, Left |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $32.48 | 2024 | Stratafix |
| Axogen | $29.35 | 2025 | |
| Biotissue Holdings INC. | $26.56 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.72 | 2022 | |
| Zimmer Biomet Holdings, INC. | $23.52 | 2019 | |
| Fx Shoulder Solutions, INC | $17.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,583,543.41 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reed Bartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.